Item 6. Selected Financial Data
8K characters. Original on sec.gov · Markdown
Item 6. Selected Financial Data
The following selected consolidated historical financial data are derived from our audited financial statements. The consolidated balance sheet data as of September 30, 2020 and 2019 and the consolidated income statement data for the years ended September 30, 2020, 2019 and 2018 are derived from our audited consolidated financial statements and related notes that are included elsewhere in this report. The consolidated balance sheet data as of September 30, 2018, 2017 and 2016 and the consolidated income statement data for the years ended September 30, 2017 and 2016 are derived from our audited consolidated financial statements and related notes which are not included in this report. The information set forth below should be read in conjunction with our historical financial statements, including the notes thereto, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included elsewhere in this report.
| Years Ended September 30, | ||||||||||||||||||||||||||||||||
| 2020 | 2019 (4) | 2018 | 2017 | 2016 | ||||||||||||||||||||||||||||
| (In thousands, except per share data) | ||||||||||||||||||||||||||||||||
| Consolidated Income Statement Data | ||||||||||||||||||||||||||||||||
| Net revenues | ||||||||||||||||||||||||||||||||
| Products | $ | 1,025,856 | $ | 985,591 | $ | 960,108 | $ | 964,662 | $ | 944,469 | ||||||||||||||||||||||
| Services | 1,324,966 | 1,256,856 | 1,201,299 | 1,125,379 | 1,050,565 | |||||||||||||||||||||||||||
| Total | 2,350,822 | 2,242,447 | 2,161,407 | 2,090,041 | 1,995,034 | |||||||||||||||||||||||||||
| Cost of net revenues | ||||||||||||||||||||||||||||||||
| Products | 215,275 | 174,986 | 181,061 | 176,032 | 166,624 | |||||||||||||||||||||||||||
| Services | 192,612 | 181,591 | 180,420 | 177,453 | 170,581 | |||||||||||||||||||||||||||
| Total | 407,887 | 356,577 | 361,481 | 353,485 | 337,205 | |||||||||||||||||||||||||||
| Gross profit | 1,942,935 | 1,885,870 | 1,799,926 | 1,736,556 | 1,657,829 | |||||||||||||||||||||||||||
| Operating expenses | ||||||||||||||||||||||||||||||||
| Sales and marketing | 843,178 | 748,619 | 664,135 | 652,239 | 628,743 | |||||||||||||||||||||||||||
| Research and development | 441,324 | 408,058 | 366,084 | 350,365 | 334,227 | |||||||||||||||||||||||||||
| General and administrative | 258,366 | 210,730 | 160,382 | 156,887 | 138,431 | |||||||||||||||||||||||||||
| Litigation expense (1) | — | — | — | 391 | 9,051 | |||||||||||||||||||||||||||
| Restructuring charges (2) | 7,800 | — | 18,426 | 12,718 | — | |||||||||||||||||||||||||||
| Total | 1,550,668 | 1,367,407 | 1,209,027 | 1,172,600 | 1,110,452 | |||||||||||||||||||||||||||
| Income from operations | 392,267 | 518,463 | 590,899 | 563,956 | 547,377 | |||||||||||||||||||||||||||
| Other income, net | 4,130 | 22,648 | 12,861 | 11,561 | 2,514 | |||||||||||||||||||||||||||
| Income before income taxes | 396,397 | 541,111 | 603,760 | 575,517 | 549,891 | |||||||||||||||||||||||||||
| Provision for income taxes | 88,956 | 113,377 | 150,071 | 154,756 | 184,036 | |||||||||||||||||||||||||||
| Net income | $ | 307,441 | $ | 427,734 | $ | 453,689 | $ | 420,761 | $ | 365,855 | ||||||||||||||||||||||
| Net income per share — basic | $ | 5.05 | $ | 7.12 | $ | 7.41 | $ | 6.56 | $ | 5.43 | ||||||||||||||||||||||
| Weighted average shares — basic | 60,911 | 60,044 | 61,262 | 64,173 | 67,433 | |||||||||||||||||||||||||||
| Net income per share — diluted | $ | 5.01 | $ | 7.08 | $ | 7.32 | $ | 6.50 | $ | 5.38 | ||||||||||||||||||||||
| Weighted average shares — diluted | 61,378 | 60,456 | 62,013 | 64,775 | 67,984 | |||||||||||||||||||||||||||
| Consolidated Balance Sheet Data | ||||||||||||||||||||||||||||||||
| Cash, cash equivalents, and short-term investments | $ | 1,209,889 | $ | 972,282 | $ | 1,039,412 | $ | 1,016,928 | $ | 882,395 | ||||||||||||||||||||||
| Restricted cash (3) | 3,270 | 3,035 | 1,187 | 1,224 | 1,151 | |||||||||||||||||||||||||||
| Long-term investments | 102,939 | 358,402 | 411,184 | 284,802 | 276,375 | |||||||||||||||||||||||||||
| Total assets | 4,677,920 | 3,390,275 | 2,605,476 | 2,476,489 | 2,306,323 | |||||||||||||||||||||||||||
| Long-term liabilities | 1,157,373 | 523,252 | 365,551 | 312,554 | 276,823 | |||||||||||||||||||||||||||
| Total shareholders’ equity | 2,232,268 | 1,761,497 | 1,285,492 | 1,229,392 | 1,185,262 | |||||||||||||||||||||||||||
(1)Litigation expense primarily represents a patent-related jury verdict and legal fees associated with the litigation.
(2)Restructuring charges represent severance and other employee-related costs associated with workforce reductions that took place in the first quarter of fiscal 2020 and the fourth quarters of fiscal 2018 and 2017.
(3)Restricted cash represents escrow accounts established in connection with lease agreements for our facilities.
(4)Selected financial data for fiscal year 2019 contains effects from the adoption of ASC 606, and differs in comparability to previous years due to those effects. See Note 2 - Revenue from Contracts with Customers for more details.
Previous: Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities · Next: Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations